No free photograph

Peter G. Schultz

American geneticist · United States · On the map · Scientists · Born 1956 · age 70

Peter G. Schultz is an American chemist, entrepreneur, and nonprofit leader. He is the CEO and president and Professor of Chemistry at Scripps Research, the founder and former director of GNF, and the founding director of the California-Skaggs Institute for Innovative Medicines, established in 2012.

Peter G. Schultz is read about 47 times a day, in 12 languages.

A typical day, 30 days to 24 June 2026

The middle day of the days counted, so one week of news cannot move it. The line under it is the last 60 days, one point a day.

Something wrong?

Compare Claim

A life in dates

2021NAS Award in Chemical SciencesAward2019Tetrahedron PrizeAward2016Heinrich Wieland PrizeAward2013Ernest Solvay PrizeAwardFellow of the American Association for the Advancement of ScienceAward2006Arthur C. Cope AwardAward2003Paul Ehrlich and Ludwig Darmstaedter PrizeAward1994Wolf Prize in ChemistryAward1991Ernest Orlando Lawrence AwardAwardNational Fresenius AwardAward1990ACS Award in Pure ChemistryAward1988Alan T. Waterman AwardAward1956Born23 June 1956

Also in Français

Awards

NAS Award in Chemical Sciences2021

Tetrahedron Prize2019

Heinrich Wieland Prize2016

Fellow of the American Association for the Advancement of Science2013

Ernest Solvay Prize2013

Arthur C. Cope Award2006

Paul Ehrlich and Ludwig Darmstaedter Prize2003

Wolf Prize in Chemistry1994

National Fresenius Award1991

Ernest Orlando Lawrence Award1991

ACS Award in Pure Chemistry1990

Alan T. Waterman Award1988

Honorary Doctor of the University of Uppsala

Alfred Bader Award in Bioinorganic or Bioorganic Chemistry

About this person

In August 2014, Nature Biotechnology ranked Schultz the #1 top translational researcher in 2013. Schultz's contributions to the field of chemistry have included the development and application of methods to expand the genetic code of living organisms, the discovery of catalytic antibodies, and the development and application of molecular diversity technologies to address problems in chemistry, biology, and medicine.

Country

United States